ETOILE: Real-World Evidence of 24 Months of Ranibizumab 0.5 mg in Patients with Visual Impairment Due to Diabetic Macular Edema

Código QR

ETOILE: Real-World Evidence of 24 Months of Ranibizumab 0.5 mg in Patients with Visual Impairment Due to Diabetic Macular Edema

Laurent Kodjikian,1 Amélie Lecleire-Collet,2 Corinne Dot,3 Marie-Laure Le Lez,4 Stéphanie Baillif,5 Ali Erginay,6 Eric Souied,7 Eric Fourmaux,8 Philippe Gain,9 Anne Ponthieux10 1Department of Ophthalmology, Croix-Rousse University Hospital, Lyon, France; 2Mathilde Clinic, Rouen...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Kodjikian L, Lecleire-Collet A, Dot C, Le Lez ML, Baillif S, Erginay A, Souied E, Fourmaux E, Gain P, Ponthieux A
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	real-world study retinal thickness visual acuity switch induction Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/50aa141a92864c05904cba97ca928361
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

One-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular Edema
por: Tran THC, et al.
Publicado: (2021)

Real-World Outcomes in Patients with Diabetic Macular Edema Treated Long Term with Ranibizumab (VISION Study)
por: Van Aken E, et al.
Publicado: (2020)

Evaluation of contrast sensitivity and other visual function outcomes in diabetic macular edema patients following treatment switch to aflibercept from ranibizumab
por: Nixon DR, et al.
Publicado: (2018)

Aflibercept versus Ranibizumab as a Second Line Therapy After Bevacizumab for Diabetic Macular Edema
por: Alsaedi NG, et al.
Publicado: (2021)

Randomised, Double-blind, Comparative Clinical Study of New Ranibizumab Biosimilar in Neovascular (Wet) Age-Related Macular Degeneration
por: Apsangikar P, et al.
Publicado: (2021)

Visual acuity and patient satisfaction at varied distances and lighting conditions after implantation of an aspheric diffractive multifocal one-piece intraocular lens
por: Chang DH
Publicado: (2016)

Comment on: “Three-year follow-up of ranibizumab treatment of wet age-related macular degeneration: influence of baseline visual acuity and injection frequency on visual outcomes”
por: Kaya A
Publicado: (2016)

Visual outcome of intravitreal ranibizumab for exudative age-related macular degeneration: timing and prognosis
por: Canan H, et al.
Publicado: (2014)

Evaluation of a paper-based visual acuity questionnaire
por: Uchino M, et al.
Publicado: (2017)

Ranibizumab treatment history as predictor of the switch-response to aflibercept: evidence for drug tolerance
por: Dirani A, et al.
Publicado: (2018)

Predictors of visual recovery in patients with macular edema secondary to central retinal vein occlusion after treatment with Conbercept
por: Qi Zhang, et al.
Publicado: (2021)

Aflibercept for clinically significant diabetic macular edema: 12-month results in daily clinical practice
por: Campos Polo R, et al.
Publicado: (2018)

Short-term outcomes in patients with branch retinal vein occlusion who received intravitreal aflibercept with or without intravitreal ranibizumab
por: Sakanishi Y, et al.
Publicado: (2017)

Intravitreal Tissue Plasminogen Activator Injection for Treatment-Resistant Diabetic Macular Edema of the Vitrectomized Eye
por: Ren Aoki, et al.
Publicado: (2021)

Baseline Subfoveal Choroidal Thickness as a Predictor for Response to Short-Term Intravitreal Bevacizumab Injections in Diabetic Macular Edema
por: Dweikat A, et al.
Publicado: (2021)

Anti-VEGF treatment of diabetic macular edema in clinical practice: effectiveness and patterns of use (ECHO Study Report 1)
por: Blinder KJ, et al.
Publicado: (2017)

Ranibizumab in the treatment of patients with visual impairment due to diabetic macular edema
por: Bandello F, et al.
Publicado: (2011)

Voltage Control of Multiphase Cage Induction Generators at a Speed Varying over a Wide Range
por: Piotr Drozdowski, et al.
Publicado: (2021)

Síndrome del creciente temporal: Reporte de un caso y revisión de la literatura
por: Mery C,Victoria, et al.
Publicado: (2004)

Resultados visuales en pacientes con macroprolactinoma tratados con agonistas de dopamina
por: Cuevas,José Luis, et al.
Publicado: (2013)

Anti-VEGF treatment of macular edema associated with retinal vein occlusion: patterns of use and effectiveness in clinical practice (ECHO study report 2)
por: Jumper JM, et al.
Publicado: (2018)

Clinical Outcome and Drug Expenses of Intravitreal Therapy for Diabetic Macular Edema: A Retrospective Study in Sardinia, Italy
por: Chiara Altana, et al.
Publicado: (2021)

Critical appraisal of ranibizumab in the treatment of diabetic macular edema
por: Stewart MW
Publicado: (2013)

Diabetic papillopathy with macular edema treated with intravitreal ranibizumab
por: Kim M, et al.
Publicado: (2013)

Baseline visual acuity strongly predicts visual acuity gain in patients with diabetic macular edema following anti-vascular endothelial growth factor treatment across trials
por: Dugel PU, et al.
Publicado: (2016)

Fístula carótido-cavernosa: importancia de su diagnóstico y tratamiento oportunos para prevenir la ceguera
por: Charlin E,Raimundo, et al.
Publicado: (2004)

Performance Phenomena in Simultaneous and Sequential Bilinguals: a Case Study of Two Chilean Bilingual Children
por: Goodman,David
Publicado: (2007)

Efficacy of Aflibercept versus Ranibizumab in the treatment of diabetic macular edema
por: Xiu-Xian Wang, et al.
Publicado: (2021)

A Comparative Study of Topicality and Writing Styles in Iranian and British Education Systems: The Cases of Deduction, Induction, and Quasi-induction
por: Mahmood Reza Moradian, et al.
Publicado: (2020)

Effectiveness of 190 μg Fluocinolone Acetonide and 700 μg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The CONSTANT Analysis
por: Zarranz-Ventura J, et al.
Publicado: (2020)

Multicenter, Prospective, Randomized Study of Dexamethasone Intravitreal Implant in Patients with Center-Involved Diabetic Macular Edema in the Asia-Pacific Region
por: Wei W, et al.
Publicado: (2021)

A Randomized, Controlled, Prospective Study of the Effectiveness and Safety of an Intracanalicular Dexamethasone Ophthalmic Insert (0.4 Mg) for the Treatment of Post-Operative Inflammation in Patients Undergoing Refractive Lens Exchange (RLE)
por: Larsen J, et al.
Publicado: (2021)

The properties of the solution for a class of switched systems with internally forced switching
por: Huanting Li, et al.
Publicado: (2021)

Assessment of quality of life in patients with visual impairments using a new visual function questionnaire: the VFQ-J11
por: Nakano T, et al.
Publicado: (2016)

MATHEMATICAL MODELLING OF TRANSIENTS IN THE ELECTRIC DRIVE OF THE SWITCH – THE MAIN EXECUTIVE ELEMENT OF RAILWAY AUTOMATION
por: S. G. Buriakovskyi, et al.
Publicado: (2020)

Effects of different types of refractive errors on bilateral amblyopia
por: Mücella Arıkan Yorgun, et al.
Publicado: (2012)

Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema
por: Fouda SM, et al.
Publicado: (2017)

Conversion to aflibercept for diabetic macular edema unresponsive to ranibizumab or bevacizumab
por: Lim LS, et al.
Publicado: (2015)

Comment on ’Effectiveness of 190 μg Fluocinolone Acetonide versus 700 μg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The CONSTANT Analysis’ [Response to Letter]
por: Zarranz-Ventura J, et al.
Publicado: (2020)

Miniature Coil for Wireless Power and Data Transfer through Aluminum
por: Juan M. Romero-Arguello, et al.
Publicado: (2021)